Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 5Head & Neck 2Endocrine 2Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Neuroendocrine Tumors 378Pituitary Neoplasms 159Multiple Endocrine Neoplasia Type 1 150Thyroid Cancer, Papillary 122Pheochromocytoma 107Carcinoma, Neuroendocrine 93Thyroid Neoplasms 74Paraganglioma 68Carcinoid Tumor 66Neoplasms 54Thyroid Carcinoma, Anaplastic 50Adrenocortical Carcinoma 47Adrenal Gland Neoplasms 46Neoplasm Metastasis 40Insulinoma 39Pancreatic Neoplasms 36Gastro-enteropancreatic neuroendocrine tumor 36Adenoma, Islet Cell 36Carcinoma, Medullary 29Neuroblastoma 28Adenocarcinoma, Follicular 28Hyperaldosteronism 25Prostatic Neoplasms 24Lung Neoplasms 24Obesity 23Brain Neoplasms 22Pituitary Diseases 21Differentiated Thyroid Cancer 20Cushing Syndrome 20Sarcoma 19

Interventions

Therapeutics 1Interpersonal Psychotherapy 1Ethanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Alcoholism × Endocrine × Clear all
NCT02358226 2020-02-17

HIV & Drug Abuse Prevention for South African Men

University of California, Los Angeles

Phase 3 Completed
1,211 enrolled
Endocrine

Acquired Immunodeficiency Syndrome, Alcoholism, Multiple Endocrine Neoplasia Type 1, Substance-Related Disorders

NCT00851669 2013-07-16

MEADOW/Bridge

University of Rochester

Phase 2 Completed
91 enrolled
Endocrine

Alcoholism, Depression, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡